Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Neuroblastoma × Amino Acids × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1 Meningioma 1 Medulloblastoma 1 Malnutrition 1 Liver Failure 1 Fibrosis 1 Carcinoma, Hepatocellular 1

Interventions

Isotretinoin 3 imetelstat 2 Peripheral Blood Stem Cell Transplantation 2 Cyclophosphamide 2 thymoglobulin 1 pazopanib 1 naxitamab 1 lorukafusp alfa 1 liposomal doxorubicin 1 keyhole-limpet hemocyanin 1 fludarabine phosphate 1 fludarabine 1 defibrotide 1 arginyllysine 1 Whole-Body Irradiation 1 Whole Body Imaging 1 Vincristine 1 Vaccines 1 Tretinoin 1 Topotecan 1 Thiotepa 1 Therapeutics 1 Temozolomide 1 Tacrolimus 1 Stem Cell Transplantation 1 Spermine Synthase 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Pentetic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03013387 2017-08-25

Dosimetry Guided PRRT With 90Y-DOTATOC

University of Iowa

Phase 2 Withdrawn

Medulloblastoma, Meningioma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡